Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Kezar Life Sciences Inc (KZR)

Kezar Life Sciences Inc (KZR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Are KZR, EQH, ULYX Obtaining Fair Deals for their Shareholders? PR Newswire - Tue Apr 14, 3:13PM CDT

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

ULYX : 5.4300 (-0.55%)
KZR : 7.33 (+0.83%)
EQH : 41.10 (-1.20%)
Are APLS, CNTA, KZR Obtaining Fair Deals for their Shareholders? PR Newswire - Fri Apr 10, 12:34PM CDT

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

KZR : 7.33 (+0.83%)
CNTA : 39.47 (+0.10%)
APLS : 40.94 (unch)
SHAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--KZR, CNTA, AFBI, and APLS PR Newswire - Wed Apr 8, 1:15PM CDT

NEW YORK , April 8, 2026 /PRNewswire/ -- Class Action Attorney  Juan Monteverde  with Monteverde & Associates PC  (the "M&A Class Action Firm"), has recovered millions of...

AFBI : 22.41 (unch)
KZR : 7.33 (+0.83%)
CNTA : 39.47 (+0.10%)
APLS : 40.94 (unch)
Are KZR, TALK, WBD Obtaining Fair Deals for their Shareholders? PR Newswire - Tue Apr 7, 1:47PM CDT

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

KZR : 7.33 (+0.83%)
WBD : 27.07 (+0.63%)
TALK : 5.18 (+0.19%)
Are KZR, NSA, EQH, CTRA Obtaining Fair Deals for their Shareholders? PR Newswire - Tue Mar 31, 10:17AM CDT

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

KZR : 7.33 (+0.83%)
EQH : 41.10 (-1.20%)
NSA : 43.33 (-0.64%)
CTRA : 33.53 (-0.36%)
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Kezar Life Sciences, Inc. (NASDAQ: KZR) PR Newswire - Mon Mar 30, 12:35PM CDT

NEW YORK , March 30, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde  with Monteverde & Associates PC  (the "M&A Class Action Firm"), has recovered millions of dollars for...

KZR : 7.33 (+0.83%)
Shareholder Alert: The Ademi Firm investigates whether Kezar Life Sciences, Inc. is obtaining a Fair Price for Public Shareholders PR Newswire - Mon Mar 30, 11:25AM CDT

MILWAUKEE , March 30, 2026 /PRNewswire/ -- Ademi LLP is investigating Kezar (NASDAQ: KZR) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction...

KZR : 7.33 (+0.83%)
KZR Stock Alert: Halper Sadeh LLC is Investigating Whether Kezar Life Sciences, Inc. is Obtaining a Fair Price for its Shareholders Business Wire - Mon Mar 30, 7:29AM CDT

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transaction may contain terms that...

KZR : 7.33 (+0.83%)
Aurinia Pharmaceuticals to Acquire Kezar Life Sciences for $6.955 in Cash per Share Plus a Contingent Value Right Business Wire - Mon Mar 30, 7:00AM CDT

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH), a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs, announced today it has...

AUPH : 15.98 (-0.99%)
KZR : 7.33 (+0.83%)
Enodia Therapeutics Strengthens Sec61 Portfolio Through Acquisition of Preclinical Assets from Kezar Life Sciences Business Wire - Thu Mar 12, 8:00AM CDT

Transaction deepens insights into Sec61 selectivity for targeted protein degradation, supporting accelerated development of Enodia’s novel small-molecule inhibitors

KZR : 7.33 (+0.83%)

Barchart Exclusives

Dan Ives: Tesla Is ‘Morphing into a Physical AI Stalwart’ So Don’t Sweat the CapEx and Just Buy TSLA Stock Barchart - Sat Apr 25, 11:00AM CDT
Wedbush’s Dan Ives is bullish on Tesla despite its increasing CapEx. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.